Andrew Webb, Pharm.D. (@AJWPharm) describes the pharmacokinetic alterations of critical illness and the implications for beta-lactam optimization, recognizes the potential role of beta-lactam therapeutic monitoring in predicting drug effectiveness, and identifies the potential role of beta-lactam therapeutic monitoring in recognizing drug toxicity.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.